The government has signalled its intention to pave the way for gene-edited crops following a consultation on departing from EU

Details on the funding of the 10-year strategy, which builds on the UK's world-class capability and on lessons from the

With the ability to provide a secure and reliable record of vaccine delivery, the technology is set to play a

Life sciences businesses working on Covid-19 related products may be able to benefit from government funding for a range of

In light of the impact of Covid-19 on businesses and the critical need for additional supplies for frontline staff and

The first article from our series "Cannabis - the 'green gold' from a legal perspective"

Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?

New parliamentary term will be packed with legislation for life sciences and healthcare businesses

This decision shows the court assessing patentability in a real-world practical context, recognising the uncertainties of R&D that only later